Skip to content
Peptide research

Ventfort

Also known as Vascular Bioregulator
Category
Bioregulators
Administration routes
Oral
Regulatory status
Not FDA-approved

What it is

A bioregulator peptide complex derived from blood vessel tissue, marketed to support vascular wall integrity and elasticity as vessels age. The case is speculative: claimed benefits for lipid profiles, atherosclerotic vessel function, and senile purpura rest on limited data, with only low-confidence signal on blood flow from related bioregulator work. Human safety data is thin. Not an approved drug in the US; supply is mostly research-grade product.

Read Full record

Studied uses & evidence

Studied uses(4)

  • Improved lipid profile (cholesterol, VLDL, triglycerides)

    Speculative

    A small institute report describes human Ventfort results, but provides weak evidence.

  • Improved vascular wall function in atherosclerosis

    Speculative

    Cell and tissue-culture studies on the related KED tripeptide show vascular effects; no human data yet.

  • Improvement in senile purpura

    Speculative

    A small institute report describes improved capillary resistance and fewer bleeding spots; reliable confirmation is lacking.

Evidence limits

Evidence Level
Limited Evidence

Ventfort has a formal clinical study with 49 patients showing improved lipid profiles and vascular function. The related synthetic peptide Vezugen has a PubMed-indexed study showing blood flow improvements. Together these provide modest supporting evidence, but studies are single-center, open-label, and have not been replicated outside Russia.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(2)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Allergic reaction to bovine vascular-derived peptides

    Low
  • Potential interaction with anticoagulants

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.